BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37600882)

  • 1. Comment on "Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".
    Meng Y; Fan Z; Yang J; Li Y; Zhan H
    Ann Surg Open; 2023 Mar; 4(1):e266. PubMed ID: 37600882
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Commentary on '"Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".
    Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR
    Ann Surg Open; 2023 Jun; 4(2):e277. PubMed ID: 37601459
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Nonfunctional Pancreatic Neuroendocrine Tumors?
    Peng MZ; Ying Y; Lou WH; Liu L; Wang WQ
    Ann Surg Open; 2023 Mar; 4(1):e249. PubMed ID: 37600884
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.
    Liu X; Chin W; Pan C; Zhang W; Yu J; Zheng S; Liu Y
    Gland Surg; 2021 Jan; 10(1):219-232. PubMed ID: 33633978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term results after parenchyma-sparing vs. oncologic resection of nonfunctional pancreatic neuroendocrine neoplasms < 3 cm].
    Maurer E; Bartsch DK
    Chirurgie (Heidelb); 2023 Apr; 94(4):365-366. PubMed ID: 36849588
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.
    Pea A; Tanno L; Nykänen T; Prasad P; Tunçer C; Robinson S; Marchegiani G
    Front Med (Lausanne); 2020; 7():559. PubMed ID: 33015105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.
    Mauriello C; Napolitano S; Gambardella C; Candela G; De Vita F; Orditura M; Sciascia V; Tartaglia E; Lanza M; Santini L; Conzo G
    Int J Surg; 2015 Sep; 21 Suppl 1():S10-4. PubMed ID: 26118605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.
    Perinel J; Nappo G; Zerbi A; Heidsma CM; Nieveen van Dijkum EJM; Han HS; Yoon YS; Satoi S; Demir IE; Friess H; Vashist Y; Izbicki J; Muller AC; Gloor B; Sandini M; Gianotti L; Subtil F; Adham M
    Surgery; 2022 Sep; 172(3):975-981. PubMed ID: 35623953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to Commentary "Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?".
    Bolm L; Nebbia M; Wei AC; Zureikat AH; Fernández-Del Castillo C; Zheng J; Pulvirenti A; Javed AA; Sekigami Y; Petruch N; Qadan M; Lillemoe KD; He J; Ferrone CR
    Ann Surg Open; 2023 Mar; 4(1):e245. PubMed ID: 37600878
    [No Abstract]   [Full Text] [Related]  

  • 10. Parenchyma-sparing resections for pancreatic neoplasms.
    Crippa S; Boninsegna L; Partelli S; Falconi M
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):782-7. PubMed ID: 19865792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
    Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
    Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study.
    Javed AA; Pulvirenti A; Zheng J; Michelakos T; Sekigami Y; Razi S; McIntyre CA; Thompson E; Klimstra DS; Deshpande V; Singhi AD; Weiss MJ; Wolfgang CL; Cameron JL; Wei AC; Zureikat AH; Ferrone CR; He J;
    Surgery; 2022 Dec; 172(6):1800-1806. PubMed ID: 36192215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic parenchyma-sparing liver resection for large (≥ 50 mm) colorectal metastases.
    Aghayan DL; d'Albenzio G; Fretland ÅA; Pelanis E; Røsok BI; Yaqub S; Palomar R; Edwin B
    Surg Endosc; 2023 Jan; 37(1):225-233. PubMed ID: 35922606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
    Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
    Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.
    Sallinen VJ; Le Large TYS; Tieftrunk E; Galeev S; Kovalenko Z; Haugvik SP; Antila A; Franklin O; Martinez-Moneo E; Robinson SM; Panzuto F; Regenet N; Muffatti F; Partelli S; Wiese D; Ruszniewski P; Dousset B; Edwin B; Bartsch DK; Sauvanet A; Falconi M; Ceyhan GO; Gaujoux S;
    HPB (Oxford); 2018 Mar; 20(3):251-259. PubMed ID: 28988702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort.
    Watley DC; Ly QP; Talmon G; Are C; Sasson AR
    Am J Surg; 2015 Dec; 210(6):1192-5; discussion 1195-6. PubMed ID: 26674063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with nonfunctional pancreatic neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: case report.
    Demirkan B; Unek IT; Eriksson B; Akarsu M; Durak H; Sağol O; Obuz F; Binicier C; Füzün M; Alakavuklar M
    Turk J Gastroenterol; 2009 Sep; 20(3):214-9. PubMed ID: 19821205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.
    Kasumova GG; Tabatabaie O; Eskander MF; Tadikonda A; Ng SC; Tseng JF
    J Am Coll Surg; 2017 Jun; 224(6):1057-1064. PubMed ID: 27965134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry.
    Mintziras I; Keck T; Werner J; Fichtner-Feigl S; Wittel U; Senninger N; Vowinkel T; Köninger J; Anthuber M; Geißler B; Bartsch DK;
    World J Surg; 2019 Jan; 43(1):175-182. PubMed ID: 30097704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.